Although the five-marker panel of CSF p-tau, CSF t-tau, SPARE-AD score, APOE genotype, and CSF Aβ42 shows less internal correlation in the PD cohort than in ADNI, these five markers might nevertheless prove useful in classifying PD-CN vs. PDD patients. This evidence concerns the gene APOE and Parkinson disease.